As of 2025-09-18, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is -38.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value is 110.73 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is -2.86 mil CAD. Dividing these 2 quantities gives us the above WLLW.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 1.4x - 2.1x | 1.8x |
| Forward P/E multiples | 2.7x - 3.0x | 2.8x |
| Fair Price | (0.01) - 0.23 | 0.11 |
| Upside | -104.2% - 32.7% | -39.1% |
| Date | EV/EBITDA |
| 2025-09-15 | -38.70 |
| 2025-09-12 | -35.40 |
| 2025-09-11 | -35.40 |
| 2025-09-10 | -33.20 |
| 2025-09-09 | -34.30 |
| 2025-09-08 | -33.20 |
| 2025-09-04 | -34.30 |
| 2025-09-03 | -35.40 |
| 2025-08-29 | -34.30 |
| 2025-08-28 | -31.00 |
| 2025-08-27 | -31.00 |
| 2025-08-26 | -33.20 |
| 2025-08-25 | -34.30 |
| 2025-08-22 | -37.60 |
| 2025-08-21 | -37.60 |
| 2025-08-20 | -37.60 |
| 2025-08-19 | -39.80 |
| 2025-08-18 | -39.80 |
| 2025-08-14 | -39.80 |
| 2025-08-13 | -39.80 |
| 2025-08-12 | -39.80 |
| 2025-08-11 | -39.80 |
| 2025-08-08 | -40.90 |
| 2025-08-07 | -39.80 |
| 2025-08-06 | -42.00 |
| 2025-08-05 | -42.00 |
| 2025-08-01 | -42.00 |
| 2025-07-31 | -40.90 |
| 2025-07-30 | -43.10 |
| 2025-07-29 | -43.10 |
| 2025-07-28 | -42.00 |
| 2025-07-25 | -42.00 |
| 2025-07-23 | -42.00 |
| 2025-07-22 | -43.65 |
| 2025-07-21 | -44.20 |
| 2025-07-18 | -46.40 |
| 2025-07-17 | -50.80 |
| 2025-07-16 | -55.20 |
| 2025-07-15 | -55.20 |
| 2025-07-14 | -55.20 |
| 2025-07-11 | -51.90 |
| 2025-07-10 | -44.20 |
| 2025-07-09 | -53.00 |
| 2025-07-08 | -55.20 |
| 2025-07-07 | -59.60 |
| 2025-07-04 | -55.20 |
| 2025-07-03 | -57.40 |
| 2025-07-02 | -58.50 |
| 2025-06-30 | -61.80 |
| 2025-06-27 | -66.20 |